63 results
DEFA14A
STRO
Sutro Biopharma Inc
26 Apr 19
Additional proxy soliciting materials
12:00am
or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials … One of the Following Voting Methods Internal Use Only Before You Vote How to Access the Proxy Materials Proxy Materials Available to VIEW or RECEIVE
DEF 14A
STRO
Sutro Biopharma Inc
26 Apr 19
Definitive proxy
12:00am
, thus reducing the environmental impact and lowering the costs of printing and distributing proxy materials without impacting your timely access … Availability) containing instructions on how to access our proxy statement for our 2019 Annual Meeting of Stockholders and our 2018 Annual Report on Form
8-K
EX-99.1
STRO
Sutro Biopharma Inc
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
of Sutro's Clinical Advisory Board.
To access the event by webcast, please click here: https://event.webcasts.com/starthere.jsp?ei=1520589&tp_key … =62ffe993bc
To access the event by phone, please dial: (877) 405-1224 or (201) 389-0848
The webcast and dial-in information will also be available through
PRE 14A
no5u6vd0q1z21j
14 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
a157tut srl700
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm